Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Clinical trial NCT02128932 · COMPLETED
Trial details
- NCT number
- NCT02128932
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-04
- Primary completion
- 2015-09-03
- Enrollment
- 1089
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.